Notice

If you want to get in contact with us you can reach us via email at ⁠associatedpodcast@gmail.com⁠ as well as on Twitter (@associated_pod).

We are trying to understand our listeners better so we can make better content. You can really help us out by filling out our listener survey which you can find here (⁠https://airtable.com/shraJVvUNv6D7PkDP⁠).

Description: On the seventh episode of our “How to Raise a Venture Fund” series, we're joined by Manuel Grossman, Founding Partner at Amino Collective, an early-stage micro fund investing at the edge of health and biology. Prior to Amino Manuel was an operator at tech bio company KRY and was a seed invetor at Allcyte acquired by Exscientia.

Amino Collective started in 2020, has over 22 investments and one exit. Their first fund was 10m EUR and have recently closed a second fund at 30m EUR with ambition of getting to 40m EUR. Amino Collective is a solo GP structure, something that is quite novel, especially in Europe. The fund mainly invests in Europe, but when advantageous also invests in select US companies.

In this episode we cover the evolution of tech bio and health tech in Europe and what has changed in the last 10 years since Manuel entered the ecosystem (i.e. before it became cool post covid), how he raised a fund without having ever been a GP and the community of emerging managers that helped him.

Deloitte's 2025 Commercial Real Estate Outlook